Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.12B$2.12Bderived−11.2% vs Q4 2017 Net Income-$261.82M-$261.82MderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$68,271,000−78.3% Operating Incomederived-$225,869,000N/M Operating Cash Flowderived-$6,920,000N/M Free Cash Flowderived-$19,304,000N/M Margins · derivedGross margin3.2%−10.0 pt vs Q4 2017
Operating margin-10.6%−10.3 pt vs Q4 2017
Net margin-12.3%−13.3 pt vs Q4 2017
ended Dec 31, 2018 · filed Mar 6, 2019 · 65 d after period end